ALS-002200
ALS-2200-101
Phase 1 small_molecule completed
Quick answer
ALS-002200 for Hepatitis C, Chronic is a Phase 1 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Hepatitis C, Chronic
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed